Raymond James Financial Services Advisors, Inc. - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 21 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2020$71,000
+6.0%
34,569
+52.3%
0.00%
Q2 2020$67,000
+26.4%
22,700
+12.4%
0.00%
Q1 2020$53,000
-41.1%
20,200
+11.0%
0.00%
Q4 2019$90,000
-17.4%
18,200
-0.3%
0.00%
Q3 2019$109,00018,2550.00%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q1 2020
NameSharesValueWeighting ↓
Eventide Asset Management 590,602$1,577,0000.02%
TPG Group Holdings (SBS) Advisors, Inc. 1,020,748$2,725,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 23,058$62,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,000$294,0000.01%
Alberta Investment Management Corp 130,000$347,0000.00%
Jaffetilchin Investment Partners, LLC 11,000$29,0000.00%
TWO SIGMA INVESTMENTS, LP 164,229$438,0000.00%
TWO SIGMA ADVISERS, LP 162,942$435,0000.00%
Janney Montgomery Scott LLC 69,487$186,0000.00%
Renaissance Technologies 391,629$1,046,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders